MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000489948

Медицинская библиотека · Stereotactic and functional neurosurgery · 2018

Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501).

Matsunaga Shigeo, Shuto Takashi, Yamamoto Masaaki, Yomo Shoji, Kondoh Takeshi, Kobayashi Tatsuya, Sato Manabu, Okamoto Hisayo, Serizawa Toru, Nagano Osamu, Kenai Hiroyuki, Obara Takuma, Iwai Yoshiyasu, Yasuda Soichiro, Hasegawa Toshinori, Kubo Kenji, Shidoh Satoka, Mori Katsuharu, Hayashi Motohiro, Inoue Akira, Onoue Shinji, Gondo Masazumi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The incidences of metastatic brain tumors from malignant melanomas have increased and survival has been prolonged by novel molecular targeted agents and immunotherapy. However, malignant melanomas are uncommon in Asian populations.

OBJECTIVES

We retrospectively analyzed treatment efficacy and identified prognostic factors impacting tumor control and survival in Japanese melanoma patients with brain metastases treated with gamma knife radiosurgery (GKRS).

METHODS

We retrospectively reviewed the medical records of 177 patients with 1,500 tumors who underwent GKRS for brain metastases from malignant melanomas. This study was conducted by the Japanese Leksell Gamma Knife Society (JLGK1501).

RESULTS

Six and 12 months after GKRS, the cumulative incidences of local tumor recurrence were 9.2 and 13.8%. Intratumoral hemorrhage (p < 0.0001) and larger tumor volume (p = 0.001) in GKRS were associated with significantly poorer local control outcomes. The use of immune checkpoint inhibitors before GKRS was significantly associated with symptomatic adverse events (p = 0.037). The median overall survival time after the initial GKRS was 7.3 months. Lower Karnofsky performance status scores (p = 0.016), uncontrolled primary cancer (p < 0.0001), and multiple brain metastases (p = 0.014) significantly influenced unfavorable overall survival outcomes. The cumulative incidences of neurological death 6 and 12 months after GKRS were 9.7 and 17.4%, those of neurological deterioration were 14.2 and 19.6%, and those of new tumor appearance were 34.5 and 40.5%.

CONCLUSIONS

The results of the present multicenter study suggest that GKRS is a relatively effective and safe modality for control of tumor progression in Japanese patients with brain metastases from malignant melanomas.

Для цитирования: Matsunaga Shigeo, Shuto Takashi, Yamamoto Masaaki, Yomo Shoji, Kondoh Takeshi, Kobayashi Tatsuya, Sato Manabu, Okamoto Hisayo, Serizawa Toru, Nagano Osamu, Kenai Hiroyuki, Obara Takuma, Iwai Yoshiyasu, Yasuda Soichiro, Hasegawa Toshinori, Kubo Kenji, Shidoh Satoka, Mori Katsuharu, Hayashi Motohiro, Inoue Akira, Onoue Shinji, Gondo Masazumi. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501).. Stereotactic and functional neurosurgery. 2018. DOI: 10.1159/000489948.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.